Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Rehavi

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Harefuah|November 12, 2005
[Pharmacogenetics: towards personalized medicine]David Gurwitz, Moshe Rehavi
Life Sciences|October 7, 2004
Hyperforin depletes synaptic vesicles content and induces compartmental redistribution of nerve ending monoaminesNetta Roz, Moshe Rehavi
Life Sciences|May 22, 2003
Hyperforin inhibits vesicular uptake of monoamines by dissipating pH gradient across synaptic vesicle membraneNetta Roz, Moshe Rehavi
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 8, 2005
Repeated swim stress leads to down-regulation of vesicular monoamine transporter 2 in rat brain nucleus accumbens and striatumMichal Zucker, Abraham Weizman, Moshe Rehavi
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 8, 2005
Decreased platelet vesicular monoamine transporter density in habitual smokersKarin Schwartz, Abraham Weizman, Moshe Rehavi
Journal of Molecular Neuroscience : MN|July 2, 2008
Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant actionMichal Reichenstein, Moshe Rehavi, Albert Pinhasov
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 15, 2002
Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2Moshe Rehavi, Netta Roz, Abraham Weizman
Trends in Pharmacological Sciences|March 12, 2003
Education: Teaching pharmacogenomics to prepare future physicians and researchers for personalized medicineDavid Gurwitz, Abraham Weizman, Moshe Rehavi
Behavioural Brain Research|January 11, 2015
Alterations in brain neurotrophic and glial factors following early age chronic methylphenidate and cocaine administrationYaarit Simchon-Tenenbaum, Abraham Weizman, Moshe Rehavi
Journal of Molecular Neuroscience : MN|July 9, 2015
The Impact of Chronic Early Administration of Psychostimulants on Brain Expression of BDNF and Other Neuroplasticity-Relevant ProteinsYaarit Simchon Tenenbaum, Abraham Weizman, Moshe Rehavi
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Harefuah|November 12, 2005
[Pharmacogenetics: towards personalized medicine]David Gurwitz, Moshe Rehavi
Life Sciences|October 7, 2004
Hyperforin depletes synaptic vesicles content and induces compartmental redistribution of nerve ending monoaminesNetta Roz, Moshe Rehavi
Life Sciences|May 22, 2003
Hyperforin inhibits vesicular uptake of monoamines by dissipating pH gradient across synaptic vesicle membraneNetta Roz, Moshe Rehavi
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 8, 2005
Repeated swim stress leads to down-regulation of vesicular monoamine transporter 2 in rat brain nucleus accumbens and striatumMichal Zucker, Abraham Weizman, Moshe Rehavi
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 8, 2005
Decreased platelet vesicular monoamine transporter density in habitual smokersKarin Schwartz, Abraham Weizman, Moshe Rehavi
Journal of Molecular Neuroscience : MN|July 2, 2008
Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant actionMichal Reichenstein, Moshe Rehavi, Albert Pinhasov
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 15, 2002
Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2Moshe Rehavi, Netta Roz, Abraham Weizman
Trends in Pharmacological Sciences|March 12, 2003
Education: Teaching pharmacogenomics to prepare future physicians and researchers for personalized medicineDavid Gurwitz, Abraham Weizman, Moshe Rehavi
Behavioural Brain Research|January 11, 2015
Alterations in brain neurotrophic and glial factors following early age chronic methylphenidate and cocaine administrationYaarit Simchon-Tenenbaum, Abraham Weizman, Moshe Rehavi
Journal of Molecular Neuroscience : MN|July 9, 2015
The Impact of Chronic Early Administration of Psychostimulants on Brain Expression of BDNF and Other Neuroplasticity-Relevant ProteinsYaarit Simchon Tenenbaum, Abraham Weizman, Moshe Rehavi
Pageof 5